Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-14

FDA Approved: FINGOLIMOD — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the supplemental application for fingolimod hydrochloride, enabling a generic version of the multiple sclerosis drug fingolimod (Fingolimod HCl) fr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod HCl (Fingolimod hydrochloride)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD HCL)